Description
Detailed description is being prepared by our clinical team.
Clinical Trials
NCT07651007
Phase 2
Not yet recruiting
Short-course RT Followed by NALIRIFOX Plus Pucotenlimab as Neoadjuvant Therapy for High-risk Locally Advanced Rectal Cancer With MSS/pMMR